VIRS vs. THNR ETF Comparison

Comparison of Pacer BioThreat Strategy ETF (VIRS) to Amplify Weight Loss Drug & Treatment ETF (THNR)
VIRS

Pacer BioThreat Strategy ETF

VIRS Description

An exchange traded fund (ETF) that seeks to track the LifeSci BioThreat Strategy Index to invest in U.S. listed companies whose products or services help to protect against, endure or recover from biological threats to human health. The index aims to: Research of current and future pandemics. Combat agents of biological warfare. Detect the presence of biological threats. Secure national borders and ports and strengthen homeland security. Aid in stockpiling of products needed in times of natural disasters and disease outbreaks. Improve food and water safety and purity. Enable technology to benefit work and stay at home mandates.

Grade (RS Rating)

Last Trade

$40.03

Average Daily Volume

368

Number of Holdings *

10

* may have additional holdings in another (foreign) market
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$24.84

Average Daily Volume

2,790

Number of Holdings *

15

* may have additional holdings in another (foreign) market
Performance
Period VIRS THNR
30 Days 2.25% -6.10%
60 Days 7.96% -7.74%
90 Days 7.86% -5.89%
12 Months 34.42%
1 Overlapping Holdings
Symbol Grade Weight in VIRS Weight in THNR Overlap
TMO F 4.92% 4.83% 4.83%
Compare ETFs